| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.95.11.2552 |
| P698 | PubMed publication ID | 9184586 |
| P2093 | author name string | Furukawa Y | |
| Ono K | |||
| Matsumori A | |||
| Sasayama S | |||
| Shioi T | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial ischemia | Q6947906 |
| P304 | page(s) | 2552-2558 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model | |
| P478 | volume | 95 |
| Q33676193 | Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET |
| Q28274092 | Activation of Notch-mediated protective signaling in the myocardium |
| Q39364649 | Acute kidney injury: emerging pharmacotherapies in current clinical trials. |
| Q38032602 | Angiogenesis in the infarcted myocardium |
| Q45865712 | Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. |
| Q36707530 | Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use? |
| Q34304413 | Blood vessel repair and regeneration in the ischaemic heart |
| Q38790312 | Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib. |
| Q34334027 | Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction |
| Q43672267 | Continuous intravenous infusion of deleted form of hepatocyte growth factor attenuates hepatic ischemia-reperfusion injury in rats |
| Q34068511 | Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis. |
| Q90027099 | Drugs in Development for Acute Kidney Injury |
| Q37723147 | Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern? |
| Q74012816 | Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function |
| Q31026830 | Focal enhancement of expression of c-Met/hepatocyte growth factor receptor in the myocardium in human myocardial infarction |
| Q35694608 | Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction |
| Q77953199 | Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart |
| Q73233056 | Gene transfer of hepatocyte growth factor improves angiogenesis and function of chronic ischemic myocardium in canine heart |
| Q54256769 | HGF/Met Axis in Heart Function and Cardioprotection. |
| Q41611766 | Heparin-mediated selective release of hepatocyte growth factor in humans |
| Q28263364 | Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release |
| Q37729853 | Hepatocyte growth factor in lung repair and pulmonary fibrosis. |
| Q74465128 | Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques |
| Q35381753 | Hepatocyte growth factor modification enhances the anti-arrhythmic properties of human bone marrow-derived mesenchymal stem cells |
| Q92135271 | Hepatocyte growth factor plays a particular role in progression of overall cardiac damage in experimental pulmonary hypertension |
| Q99352829 | Hepatocyte growth factor predicts failure of Fontan circulation |
| Q43755855 | Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis |
| Q33555638 | Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage |
| Q36740263 | Hepatocyte growth factor regulates angiotensin converting enzyme expression |
| Q77659268 | Hepatocyte growth factor(HGF): a new biochemical marker for acute myocardial infarction |
| Q35011205 | Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells |
| Q64375164 | Improvement of heart function in postinfarct heart failure swine models after hepatocyte growth factor gene transfer: comparison of low-, medium- and high-dose groups |
| Q43429970 | In vivo gene gun-mediated transduction into rat heart with Epstein-Barr virus-based episomal vectors |
| Q58786498 | Injury-induced fetal reprogramming imparts multipotency and reparative properties to pericardial adipose stem cells |
| Q42644713 | Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction |
| Q44611913 | Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study |
| Q52536744 | Ischemia-reperfusion in the adult mouse heart influence of age. |
| Q39716356 | Late intervention with the small molecule BB3 mitigates postischemic kidney injury |
| Q33557290 | MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium |
| Q40761395 | Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. |
| Q34784692 | Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs |
| Q36067773 | Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. |
| Q91715702 | Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction |
| Q28305555 | Novel therapy for myocardial infarction: can HGF/Met be beneficial? |
| Q37635850 | Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease |
| Q50867981 | Pathological and molecular analyses of atherosclerotic lesions in ApoE-knockout mice. |
| Q28288230 | Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease |
| Q35375482 | Production of hepatocyte growth factor during acute myocardial infarction |
| Q34114279 | Recent developments in gene therapy for cardiac disease |
| Q35140094 | Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factors |
| Q41530165 | Role of miR-128 in hypertension-induced myocardial injury |
| Q77058186 | Sinusoidal endothelial cell injury during hepatic preservation and reperfusion |
| Q38402505 | Stroke Induces Mesenchymal Stem Cell Migration to Infarcted Brain Areas Via CXCR4 and C-Met Signaling |
| Q36466672 | Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D. |
| Q27321286 | Sustained functional improvement by hepatocyte growth factor-like small molecule BB3 after focal cerebral ischemia in rats and mice |
| Q46252047 | TNF-alpha employs a protein-tyrosine phosphatase to inhibit activation of hepatocyte growth factor receptor and hepatocyte growth factor-induced endothelial cell proliferation |
| Q37520596 | Targeting angiogenesis to restore the microcirculation after reperfused MI. |
| Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
| Q44811518 | Teratogenic effects of bis-diamine on the developing myocardium |
| Q30664734 | Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease |
| Q51683026 | Utility of Hepatocyte Growth Factor as a Biomarker for Early Diagnosis of Pulmonary Artery Hypertension. |
| Q35559077 | Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner |
| Q33889422 | hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure |
Search more.